Literature DB >> 21771364

[Summary of the practice guideline 'The Prevention Visit' from the Dutch College of General Practitioners].

Jacqueline M Dekker1, Marjan Alssema, Paul G H Janssen, Lex N Goudswaard.   

Abstract

The aim of the practice guideline 'The Prevention Visit' is the prevention of cardiovascular diseases, type 2 diabetes and chronic kidney injury in adults not previously diagnosed with hypertension, hypercholesterolaemia, or the above-mentioned cardiometabolic disorders. This is done by actively offering risk assessment combined with relevant treatment and advice (if indicated), integrated into primary health care. A self-report questionnaire is used to identify persons at high risk of developing cardiometabolic disease. Individuals with a risk score above the established threshold are advised to visit their general practitioner for measurement of height, weight, waist circumference, blood pressure, fasting glucose, cholesterol, and HDL cholesterol. At a subsequent practice visit, a risk assessment is performed according to the Dutch College of General Practitioners' practice guideline 'Cardiovascular Risk Management', at which time the patient's lifestyle is evaluated. If indicated, the general practitioner will initiate support and treatment according to relevant practice guidelines established by the Dutch College of General Practitioners.

Entities:  

Mesh:

Year:  2011        PMID: 21771364

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  9 in total

1.  Bridging the gap between public health and primary care in prevention of cardiometabolic diseases; background of and experiences with the Prevention Consultation in The Netherlands.

Authors:  Willem J J Assendelft; Markus M J Nielen; Dries M Hettinga; Victor van der Meer; Mieke van Vliet; Antonius J M Drenthen; Francois G Schellevis; Marianne J W van Oosterhout
Journal:  Fam Pract       Date:  2012-04       Impact factor: 2.267

2.  External Validation of a Tool Predicting 7-Year Risk of Developing Cardiovascular Disease, Type 2 Diabetes or Chronic Kidney Disease.

Authors:  Simone P Rauh; Femke Rutters; Amber A W A van der Heijden; Thomas Luimes; Marjan Alssema; Martijn W Heymans; Dianna J Magliano; Jonathan E Shaw; Joline W Beulens; Jacqueline M Dekker
Journal:  J Gen Intern Med       Date:  2017-12-04       Impact factor: 5.128

3.  Favourable outcomes of a preventive screening and counselling programme for older people in underprivileged areas in the Netherlands: The PRIMUS project.

Authors:  D J Annemarie van Dijk; Matty R Crone; Pepijn van Empelen; Willem J Assendelft; Barend J Middelkoop
Journal:  Prev Med Rep       Date:  2017-03-22

4.  External validation of the European risk assessment tool for chronic cardio-metabolic disorders in a Middle Eastern population.

Authors:  Samaneh Asgari; Fatemeh Moosaie; Davood Khalili; Fereidoun Azizi; Farzad Hadaegh
Journal:  J Transl Med       Date:  2020-07-02       Impact factor: 5.531

5.  High Variability in Implementation of Selective-Prevention Services for Cardiometabolic Diseases in Five European Primary Care Settings.

Authors:  Christos Lionis; Marilena Anastasaki; Antonios Bertsias; Agapi Angelaki; Axel C Carlsson; Hrafnhildur Gudjonsdottir; Per Wändell; Anders Larrabee Sonderlund; Trine Thilsing; Jens Søndergaard; Bohumil Seifert; Norbert Kral; Niek J De Wit; Monika Hollander; Joke Korevaar; François Schellevis
Journal:  Int J Environ Res Public Health       Date:  2020-12-04       Impact factor: 3.390

6.  Cardiovascular screening in general practice in a low SES area.

Authors:  Ans H Tiessen; Andries J Smit; Sebes Zevenhuizen; Edwin M Spithoven; Klaas Van der Meer
Journal:  BMC Fam Pract       Date:  2012-12-10       Impact factor: 2.497

7.  Health care providers' perspective on using family history in the prevention of type 2 diabetes: a qualitative study including different disciplines.

Authors:  Suzanne C M van Esch; Wieke H Heideman; Wilmy Cleijne; Martina C Cornel; Frank J Snoek
Journal:  BMC Fam Pract       Date:  2013-03-07       Impact factor: 2.497

8.  Screen or not to screen for peripheral arterial disease: guidance from a decision model.

Authors:  Anil Vaidya; Manuela A Joore; Arina J Ten Cate-Hoek; Hugo Ten Cate; Johan L Severens
Journal:  BMC Public Health       Date:  2014-01-29       Impact factor: 3.295

Review 9.  An evidence-based toolbox for the design and implementation of selective-prevention primary-care initiatives targeting cardio-metabolic disease.

Authors:  Anders Larrabee Sonderlund; Trine Thilsing; Joke Korevaar; Monika Hollander; Christos Lionis; Francois Schellevis; Per Wändell; Axel C Carlsson; Anne-Karien de Waard; Niek de Wit; Bohumil Seifert; Agapi Angelaki; Norbert Kral; Jens Sondergaard
Journal:  Prev Med Rep       Date:  2019-08-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.